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Background
The demand for high yield recombinant protein produc-
tion systems has focused industry on culture media and
feed strategies that optimize productivity, yet maintain
product quality attributes such as glycosylation. Minimiz-
ing media components such as glucose, reduces the pro-
duction of lactate, but may also affect glycosylation. The
first steps in the glycosylation pathway involve the synth-
esis of lipid-linked oligosaccharides (LLOs). Glycan macro-
heterogeneity is introduced by variation in site-specific
glycosylation with the transfer of the oligosaccharide to
the protein. Further modification of the oligosaccharide
can occur through processing reactions, where some
sugars are removed and additional sugars added. This
produces microheterogeneity of the glycan pool. Both
macroheterogeneity and microheterogeneity may be
affected by fermentation conditions. The objective of this
study has been to investigate the effect of variable concen-
trations of glucose on the glycosylation patterns of a came-
lid monoclonal antibody produced in Chinese hamster
ovary (CHO) cells and to further evaluate their effect on
components of the N-glycosylation pathway.
Materials and methods
A CHO cell line recombinantly expressing chimeric
antibodies EG2 with a camelid single domain fused to
human Fc regions was used in this study. Cells were
inoculated at 2.6 x 106 cells/ml into 7 shake flasks (250 ml)
each containing 80 ml of media with a different initial
glucose concentration varying from 0 to 25 mM. The
cultures were maintained and monitored under standard
shaking conditions in an incubator over a 24 hr period.
Cells were harvested and quenched to stop any subse-
quent metabolic activities [1]. LLOs were extracted from
the cells using a previously established method [2]. Mild
acid cleaved glycans were labeled with 2-aminobenzamide
and analyzed by high performance liquid chromatography
(HPLC) using the technique of hydrophilic interaction
liquid chromatography (HILIC). The structures were
assigned using standard GU values from the GlycoBase
database (NIBRT.ie) [3] and confirmed by Mass spectro-
metric analysis.
Antibodies were purified from culture supernatants with
a Protein A affinity column and run under denaturing
conditions on 8-16% SDS-PAGE gels and stained with
Coomassie Brilliant Blue (CBB). The density ratio between
upper and lower bands was determined by densitometry.
The protein bands were removed by scalpel, washed, and
treated with Peptide-N-Glycosidase F for 18 h to remove
the attached glycans. MS analysis was carried out on the
MALDI-TOF/TOF mass spectrometer to confirm aglyco-
sylated Mabs in the lower band, and glycosylated proteins
present in the upper band. The isolated N-linked glycans
were labeled with 2-AB [4]. Glycan structures were
assigned using standard GU values from HILIC analysis
in GlycoBase. Structures were confirmed by exoglycosi-
dase enzymatic digestion arrays according to method of
Royle et al (2010).
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Results
Peaks corresponding to the LLOs from each of the pre-
viously described cultures with varying glucose concentra-
tion cultures were compared (Figure 1.A.). Samples from
cultures containing 25mM glucose displayed a prominent
large peak with a GU value of 11.7 representing 63% of
the total LLOs and designated as the Glc3Man9GlcNAc2a
structure (Figure 1.A.). Small peaks were designated as
Glc2Man9GlcNAc2, Glc1Man9GlcNAc2, Man9GlcNAc2,
Man5GlcNAc2 and Man2GlcNAc2 structures. For cells
grown at an initial glucose concentration of less than 15
mM the predominant peak was Man2GlcNAc2 with a
significant level of the Man5GlcNAc2 structure but the
percentage of the Glc3Man9GlcNAc2 structure was
reduced significantly to 2.9% of the overall LLOs. It is
important to note that these cultures (≤15mM glucose)
were under conditions of glucose depletion for at least 4 h
prior to harvest.
LLO with a completed glycan structure Glc3Man9Glc-
NAc2 is an essential precursor for N-glycosylation.
Thus, the effect of glucose concentration on the macro-
heterogeneity and microheterogeneity of the fully formed
glycoprotein were examined next. Protein A purified
antibodies from cultures after 24 h were analyzed on
reduced SDS-PAGE gels 1. B. The antibodies produced
by cells grown in 17.5-25 mM glucose displayed one
single strong band corresponding to the glycosylated
heavy chain. Proteins isolated from cell culture with
15 mM initial glucose concentration (Lane 5) showed a
faint band underneath the predominant gel band. The
Figure 1 The availability of glucose to CHO cells affects the intracellular lipid-linked oligosaccharide distribution, site occupancy and
the N-glycosylation profile of a monoclonal antibody. A. Lipid-linked oligosaccharide (LLO) profiles. The glycans from each sample were acid
hydrolyzed from the lipid carriers, 2-AB labeled and detected by HILIC. (Glc Δ Man Ο and GlcNAc ?). B. Separation of EG2 antibodies on reduced
8-16% SDS-PAGE gel. The purified antibody in lane 8 was isolated from the culture prior to the 24 h incubation. Upper bands in lanes 1 to 4
correspond to glycosylated antibodies, and the lower bands were determined to be non-glycosylated antibodies. C. HPLC profiles of N-glycans
isolated from EG2 antibodies produced by CHO cells with various initial glucose concentrations during a 24 h incubation. D. The effect of
exposure time of cells to media depleted of glucose on the galactosylation (GI; ¦) and the sialylation (SI; ?) indices of EG2 antibodies produced
by CHO cells.
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proportional density of the lower band in the 12.5 mM
glucose sample was 26% which increased gradually to
52% for samples taken from cultures with no added
glucose (Table 1). The lower protein bands were sus-
pected to be deglycosylated proteins due to an estimated
2% weight loss, which corresponds to the typical mass of
glycan found on IgGs [5]. Samples of antibody showing
two gel bands were analyzed by MALDI-MS. This
showed m/z values of 82,670 and 79,350 which are the
expected masses of the glycosylated and non-glycosylated
forms, respectively of the complete antibodies.
To compare the difference in glycosylation profiles of
EG2 antibodies induced by various glucose concentrations,
the glycans were released from the Protein A-purified
Mabs with PNGase F, and analyzed by HILIC HPLC. The
glycan pool was separated into six major peaks which
eluted between 33 and 43 minutes with corresponding
GU values between 5 and 9 (Figure 1. C.). Structures were
provisionally assigned from GU values with reference to
the Glycobase and confirmed by a series of exoglycosidase
enzyme array digestions. This allowed the identification of
biantennary glycan structures with variable galactosylation,
fucosylation and sialylation. The predominant glycan
structure of antibodies isolated from the 25 mM glucose
culture was the fully galactosylated biantennary and fuco-
sylated structure, Fuc(6)GlcNAc2Gal2 , which comprised
60% of the overall glycans. Fuc(6)GlcNAc2Gal0 and Fuc
(6)GlcNAc2Gal2 structures were determined at 6% and
34%, respectively. The structures were found in samples
from all cultures analyzed but there was a significant shift
to lower galactosylation and sialylation in samples derived
from cultures with lower glucose.
a Glc, glucose; Man, mannose; GlcNAc, N-acetyl-
glucosamine.
b Fuc, fucose; Gal, galactose.
Each glycan pool was assigned a galactosylation index
(GI) and a sialylation index (SI) based upon the relative
peak areas on the HPLC profile. In this experiment the
GI value changed from 0.35 to 0.72 as the availability of
glucose increased for the cells. Sialylation is dependent
upon prior galactosylation of a glycan and consequently
shows lower values with corresponding SI values from
0.019 to 0.058. There was a strong positive correlation
between the GI and SI value determined for each sample
and the time spent by the corresponding cells in glucose
deprived media over the 24 h experimental period
(R2 = 0.965 and 0.936 for the GI and SI values respec-
tively; Figure 1.D.).
Conclusion
N-glycosylation is an important post-translation modifi-
cation in mammalian cells, which is known to impact
the quality and efficacy of therapeutic recombinant
proteins. In this study, we focused on the effect of glu-
cose concentration on several aspects in N-glycosylation
pathways in CHO-EG2 cells. The depletion of glucose
as the main carbohydrate source during cell culture, can
reduce the capacity for N-glycosylation. Reduced avail-
ability of the full-length LLO precursor occurred by
glucose deprivation and resulted in the accumulation of
truncated dolichol linked glycans. This led to reduced
glycosylation in the EG2 antibodies. Glucose deprivation
also led to changes in microheterogeneity with a decrease
in galactosylation and sialylation. It is concluded that low
glucose concentrations in culture altered LLO synthesis
and N-glycan profiles of the antibody.
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